InBody Co., Ltd. announces an Equity Buyback for KRW 4,000 million worth of its shares.
December 21, 2018
Share
InBody Co., Ltd. (KOSDAQ:A041830) announces a share repurchase program. Under the program, the company will repurchase up to KRW 4,000 million worth of its shares, pursuant to a contract with Shinhan Investment Corp. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on December 20, 2019. As of December 20, 2018, the company had 201,142 shares in treasury within scope available for dividend and had no shares in treasury under other capacities.
InBody Co., Ltd., formerly Biospace Co., Ltd., is a Korea-based company engaged in the manufacture of electronic medical devices. The Company mainly produces body composition analyzers under the brand names of InBody and LookinâBody. The Company mainly produces body composition analyzers under the brand name InBody and LookinâBody. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include LookinâBody3.0 and LookinâBody Basic, which are used for measuring proteins, minerals, fats, moistures and others. It also provides body mass index (BMI) measuring devices under the brand name of BSM. The Company distributes its products within domestic market and to overseas markets.
INBODY CO.,LTD 
